Acutus Medical said today it launched the AcQMap high-resolution imaging & mapping system and the 3D mapping catheter that goes by the same name, touting that the system had been used in its first commercial procedures.
The Carlsbad, Calif.-based company said that AcQMap system is designed to detect and display standard voltage-based and higher resolution charge-source maps, and is able to generate real-time, 3D images of the heart chamber using ultrasound.
“Enabling physicians to see complex, irregular arrhythmias in real-time should provide important new insights and enable truly personalized and individualized ablation therapy planning. We hope that this unique capability, combined with the ability to quickly re-map after each ablation, will lead the way to further improvements in clinical outcomes for patients suffering from complex arrhythmias. Together with institutions across the country, we hope to transform the lives of people suffering from complex arrhythmias through our innovative technology and are pleased that U.S. patients now have access to AcQMap,” prez & CEO Vince Burgess said in a press release.
Acutus Medical said that it has also launched a clinical study of the device exploring its use during atrial fibrillation retreatment ablation procedures.
Last October, Acutus Medical said that it won 510(k) clearance from the FDA for its AcQMap system. The system won CE Mark approval in the European Union in May 2016.
